TP53 (G249 T, G249A, T176C, C250 T, and T238 G) and nucleophosmin mut.A (a duplication of the TCTG at positions 956–959) mutations were found in cfDNA from patients with acute myelogenous leukemia (AML) and non-Hodgkin's lymphoma (NHL) (Hosny et al., 2009; Quan et al., 2015). Here, TP53 is linked to non-Hodgkin lymphoma.